Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-02-03 @ 11:26 AM
Study NCT ID:
NCT03836066
Status:
COMPLETED
Last Update Posted:
2025-12-04
First Post:
2019-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Atezolizumab Plus Bevacizumab in First Line NSCLC Patients
Sponsor:
Organization: